Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Can web 2.0 reboot clinical trials?

An Erratum to this article was published on 01 February 2010

This article has been updated

Dozens of companies are trying to leverage social networking and other software tools to accelerate trials and reduce their cost.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 3: Google founder Sergey Brin has become part of the clinical trial revolution on the web.
Figure 2: TrialX iPhone app lets patients and doctors search for clinical trials by location, indication or treatment, share it with friends or family, and call a clinical trial investigator.

Change history

  • 05 February 2010

    In the version of this article initially published, Sharib Khan was incorrectly identified as the CEO of TrialX. He is cofounder. The error has been corrected in the HTML and PDF versions of the article.

References

  1. Westing, A.F. How the Public Views Privacy and Health Research (National Academy of Sciences, Washington, DC, 2007).

    Google Scholar 

  2. Arnst, C. Health 2.0, Patients as Partners, Business Week, December 4, 2008 http://www.businessweek.com/magazine/content/08_50/b4112058194219.htm

    Google Scholar 

  3. Ramsey, S. & Scoogins, J. Practicing on the tip of an iceberg? Evidence of underpublication of registered clinical trials in oncology. Oncologist 13, 925–929 (2008).

    Article  Google Scholar 

  4. Kurzrock, R. et al. Project zero delay: a process for accelerating the activation of cancer clinical trials. J. Clin. Oncol. 27, 4433–4440 (2009).

    Article  Google Scholar 

  5. Greggio, E. & Cookson, M.R. Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions. ASN Neuro. published online, doi: 10.1042/AN20090007 (14 April 2009).

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Allison, M. Can web 2.0 reboot clinical trials?. Nat Biotechnol 27, 895–902 (2009). https://doi.org/10.1038/nbt1009-895

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1009-895

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing